US medical device manufacturers typically launch new products in Asia only after establishing success in the US and Europe. However, decisions made in the product development process have significant impact on regulatory costs, time to market and ultimately sales results in Asia. Address these four points to ensure fastest time-to-revenue in Asian markets.
If you are not happy with the results below please do another search
13 search results for:
The Thai FDA increased the regulatory status of alcohol-based sterilization devices from General to Class 2 Notified.